AliveDx has submitted a 510(k) premarket notification seeking approval from the US Food and Drug Administration (FDA) for its MosaiQ AiPlex Connective Tissue Diseases (CTDplus) microarray. This ...

Microarray technology encompasses a few relatively ... and 2,000 copies of a particular molecule in diseased and normal tissue, respectively. For any antisense experiment, for example, the design ...

AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ ...

We applied the miRCURY LNA microarray platform to generate miRNA expression profiles of breast cancer tissue and normal adjacent breast tissue to identify possible new biomarkers for breast cancer 9.

tissue microarray and in situ hybridization services for both human and animal tissues. Services are open to all Cancer Center members on an equal basis. Samples are for research purposes only and may ...

We are now using microarray analysis to identify the transcriptional targets of Eve and Runt that contribute directly to these differences between cells. Functional analysis of such target genes will ...

Tissue/cell processing and embedding Tissue slide sectioning H&E staining Special stains including: PAS, ORO, Trichrome, VVG for elastin, Giemsa Sectioning of thick tissue curls or core punches for ...

This can be detected on the microarray. The first step in using a microarray is to collect healthy and cancerous tissue samples from the patient. This way, doctors can look at what genes are ...

Biological complexity is often masked by bulk sequencing and microarray techniques, which provide an average snapshot of how cells work. In contrast, single-cell sequencing technology allows ...